Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

The smaller Mobi pump for more active users was launched in 2024, and the Sigi patch pump is in development. With this range of products, we think it’s likely Tandem can address a wider swath of both ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous ...